60 related articles for article (PubMed ID: 1726989)
1. [Determination of susceptibility to pharmacologic treatment in Graves'-Basedow disease].
Grzywa M; Maciejko-Meresta B
Pol Tyg Lek; 1991 Oct 28-Nov 4; 46(43-44):822-3. PubMed ID: 1726989
[TBL] [Abstract][Full Text] [Related]
2. [Antibodies against TSH receptors (TRAb) as indicators in prognosing the effectiveness of Tiamazol therapy for Grave's Disease].
Bojarska-Szmygin A; Ciechanek R
Wiad Lek; 2003; 56(7-8):303-7. PubMed ID: 14969154
[TBL] [Abstract][Full Text] [Related]
3. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
Schumm-Draeger PM
Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
5. Prediction of remission or relapse for Graves' hyperthyroidism by the combined determination of stimulating, blocking and binding TSH-receptor antibodies after the withdrawal of antithyroid drug treatment.
Wallaschofski H; Miehle K; Mayer A; Tuschy U; Hentschel B; Paschke R
Horm Metab Res; 2002 Jul; 34(7):383-8. PubMed ID: 12189586
[TBL] [Abstract][Full Text] [Related]
6. The distribution of the major peripheral blood T, B and NK cell subsets does not predict the clinical outcome of Graves' disease patients after methimazole therapy.
Corrales JJ; López A; Ciudad J; Orfao A
J Biol Regul Homeost Agents; 2000; 14(3):193-9. PubMed ID: 11037052
[TBL] [Abstract][Full Text] [Related]
7. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
Bürgi U; Gerber H; Peter HJ
Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of M22-based assays for TSH-receptor antibody (TRAb) in the follow-up of antithyroid drug treated Graves' disease: comparison with the second generation human TRAb assay.
Massart C; Gibassier J; d'Herbomez M
Clin Chim Acta; 2009 Sep; 407(1-2):62-6. PubMed ID: 19576193
[TBL] [Abstract][Full Text] [Related]
10. High iodine (substrate) turnover Graves' disease: the intriguing 'rapid responder' variant of thyrotoxicosis.
Dalan R; Leow MK; Ng DC
Ann Clin Biochem; 2008 Nov; 45(Pt 6):612-5. PubMed ID: 18941129
[TBL] [Abstract][Full Text] [Related]
11. Remission of Graves' hyperthyroidism treated with methimazole.
Bolaños F; González-Ortiz M; Durón H; Sánchez C
Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
[TBL] [Abstract][Full Text] [Related]
12. [Individual outcome monitoring of TSH receptor antibody level for predicting the prognosis of Graves' disease].
Rink T; Holle LH; Schroth HJ; Garth H
Nuklearmedizin; 1998 May; 37(3):90-4. PubMed ID: 9604228
[TBL] [Abstract][Full Text] [Related]
13. [Basedow disease in a young boy].
Andersen UM
Ugeskr Laeger; 1993 Oct; 155(40):3213-5. PubMed ID: 7694411
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of management of Graves' disease in District General Hospital: achievement of consensus guidelines.
Dasgupta S; Savage MW
Int J Clin Pract; 2005 Sep; 59(9):1097-100. PubMed ID: 16115188
[TBL] [Abstract][Full Text] [Related]
15. Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study.
Glaser NS; Styne DM;
Pediatrics; 2008 Mar; 121(3):e481-8. PubMed ID: 18267979
[TBL] [Abstract][Full Text] [Related]
16. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
Berg GE; Michanek AM; Holmberg EC; Fink M
J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
[TBL] [Abstract][Full Text] [Related]
17. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
[TBL] [Abstract][Full Text] [Related]
18. [Graves-Basedow disease and pregnancy].
Hanzlik J; Mardarowicz G
Pol Tyg Lek; 1976 Dec; 31(52):2239-41. PubMed ID: 63945
[No Abstract] [Full Text] [Related]
19. Graves' disease, thymus enlargement, and hypercalcemia.
Giovanella L; Suriano S; Ceriani L
N Engl J Med; 2008 Mar; 358(10):1078-9. PubMed ID: 18322294
[No Abstract] [Full Text] [Related]
20. [Antithyroid and TSH-suppressive treatment in Basedow disease?].
Mann K; Hörmann R
Internist (Berl); 1998 Jun; 39(6):610-2. PubMed ID: 9677519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
